NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript

NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript October 30, 2024

NovoCure Limited beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.34.

Operator: Good day, and thank you for standing by. Welcome to the NovoCure Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is...